#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Macular telangiectasia Marginal zone lymphoma refractory Vitamin B12 deficiency Selective polysaccharide antibody deficiency Anal fistula PIK3CA-activated mutation Hairy cell leukaemia recurrent Oropharyngeal cancer recurrent Plasma cell myeloma Cytokine release syndrome Anaemia Von Willebrand's disease Congenital myopathy Haemophilia B with anti factor IX Congenital aplastic anaemia More trials…

    Learn about Rare Diseases

    Rhabdomyosarcoma recurrent – Trials in Disease Mucopolysaccharidosis – Treatment Anaplastic thyroid cancer – Life with Disease Lymphatic malformation – Treatment Haemophilia A with anti factor VIII – Life with Disease Mastocytosis – Basic Information Primary hyperoxaluria – Trials in Disease Cystic fibrosis lung – Basic Information Waldenstrom’s macroglobulinaemia – Trials in Disease Undifferentiated sarcoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Methoxyflurane CARBACHOL Dexlansoprazole Mycophenolic Acid DCC-3084 Bosentan Encaleret Sulfate Levodopa Ivabradine Dermatophagoides Pteronyssinus Golodirsen Valproic Acid Cdr132L L-ARGININE Dapagliflozin Litenimod Sodium Acasunlimab Rbl015.2 Efgartigimod Alfa Mezigdomide More therapies…

    Learn about Your Condition

    Hypoaesthesia Cystic fibrosis Dizziness Atopic keratoconjunctivitis Bipolar I disorder Follicular lymphoma stage III Erdheim-Chester disease Polyneuropathy Anal fistula Mixed dementia Uveitis Reperfusion injury Hyperphagia Respiratory tract infection Sciatica More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Lennox-Gastaut syndrome

  • A study to evaluate the effectiveness and safety of clemizole hydrochloride as an additional treatment for patients with Lennox-Gastaut syndrome

    Recruiting

    3 1
    Investigated Diseases:
    • Lennox-Gastaut syndrome
    Investigated Drugs:
    • Clemizole Hydrochloride
    Czechia Hungary Italy Poland Romania Spain

  • Study on Carisbamate for Treating Seizures in Children and Adults with Lennox-Gastaut Syndrome

    Recruiting

    3 1
    Investigated Drugs:
    • Carisbamate
    Germany Greece Hungary Italy Poland Portugal +1

  • Long-Term Safety Study of Fenfluramine Hydrochloride for Seizures in Patients with Dravet or Lennox-Gastaut Syndrome

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Lennox-Gastaut syndrome
    • Severe myoclonic epilepsy of infancy
    Investigated Drugs:
    • Fenfluramine Hydrochloride
    Italy The Netherlands Poland Spain

  • Study on Long-Term Safety of Soticlestat for Patients with Dravet or Lennox-Gastaut Syndromes

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Soticlestat
    Belgium France Germany Greece Hungary Italy +4

  • Study on Soticlestat for Children and Adults with Dravet or Lennox-Gastaut Syndrome Previously Treated with Fenfluramine

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Lennox-Gastaut syndrome
    • Severe myoclonic epilepsy of infancy
    Investigated Drugs:
    • Soticlestat
    Denmark

  • Study on Cannabidiol Oral Solution for Infants with Tuberous Sclerosis, Dravet Syndrome, or Lennox-Gastaut Syndrome Experiencing Uncontrolled Seizures

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Lennox-Gastaut syndrome
    • Severe myoclonic epilepsy of infancy
    • Tuberous sclerosis complex
    Investigated Drugs:
    • Cannabidiol
    Italy Spain
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!